Viewing Study NCT00144703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:21 PM
Ignite Modification Date: 2026-01-24 @ 11:58 PM
Study NCT ID: NCT00144703
Status: COMPLETED
Last Update Posted: 2012-01-26
First Post: 2005-09-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematologic Malignancies View
None Myelogenous Leukemia View
None Acute Lymphoblastic Leukemia View
None Myelodysplastic Syndrome View
None Non-Hodgkin's Lymphoma View
None Hodgkin's Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graft versus host disease View
None GVHD View
None Stem cell transplantation View
None sirolimus View
None tacrolimus View